Ramius Advisors’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-395,947
Closed -$33.7M 168
2020
Q3
$33.7M Buy
+395,947
New +$20M 8.12% 3

Ramius Advisors's IMMU Position: Q4 2020 in Review

Ramius Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 395,947 shares — an estimated $33.7M sold.

Ramius Advisors first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $33.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Ramius Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Ramius Advisors sold 395,947 Immunomedics Inc shares in Q4 2020, an estimated $33.7M.
  • Ramius Advisors first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Ramius Advisors's Immunomedics Inc position peaked at $33.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Ramius Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.